Navigation Links
US Patent Granted To Chrono Therapeutics Inc. For Its Chrono-Pharmacological Drug Delivery Systems And Applications
Date:6/4/2010

Patent Protection extends at least to 2025

Hamilton, NJ (PRWEB) June 4, 2010 -- Chrono Therapeutics Inc. (Chrono), a privately held company that pioneers chrono therapeutic health care products, announced today that it has been awarded another United States patent to protect its chrono-pharmacological systems and applications.

Guy DiPierro, CEO of Chrono, noted that this new patent grant enhances Chrono’s exclusivity for what is believed to be the next revolutionary change in therapeutics-namely tailored chrono-pharmacological therapies. Mr DiPierro noted that this new patent grant also affirms the novelty of Chrono’s technology and believes it will considerably reduce any potential risk to the Chrono group.

About Chrono Therapeutics Inc. Intellectual Property (IP)

Chrono Therapeutics’ IP estate includes issued, allowed, and granted fundamental patents in several of the world’s major pharmaceutical markets. This IP protects Chrono’s chrono-pharmacological applications and non-invasive drug delivery systems. Additional patents are and will soon be pending worldwide.

About Chrono Therapeutics Inc.

Chrono Therapeutics Inc. is specialty pharmaceutical company developing novel therapeutic systems and methods to become the global leader in Chrono Therapeutic based drug products. The significant advantages of chrono therapeutic based therapies have now become widely recognized and are quickly coming to the forefront as the next major advance in treating indications. The company is applying its therapeutic expertise to develop these chrono therapeutic and tailored applications that seek to dramatically increase efficacy over traditional non-tailored applications while decreasing adverse side effects and accumulated tolerance. The company’s leadership with chrono therapeutic optimized application and methodologies and fundamental patents, technology, and know-how has proven key in forming major alliances with leading companies worldwide.

Contact:
Chrono Therapeutics Inc.
Guy DiPierro, Chief Executive Officer
Email: Info(at)ChronoDose(dot)com
Website: www.ChronoDose.com

###

Read the full story at http://www.prweb.com/releases/CHRONO2010/06/prweb4084784.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dr. Jay Calvert MD Announces Details on New Patent-Protected Investigational Breast Implants
2. Haemonetics Files a New Legal Action to Stop Fenwal Inc.s Continued Patent Infringement
3. United States Patent Office Allows CareRise Patent on 24/7 Staff-Census Software
4. OmniActive and Kemin Reach Amicable Settlement in Patent Dispute
5. Patent Granted on GenerOs EX, A Medical Device That Helps Bones Grow
6. American Diversified Holdings Corporation Announces Stem Cell Patent Acquisition Program
7. MindUp (HIRU) Patents in the World Patent Database
8. GenomeQuest Hosts Seminar Focused On Web-based Searching for Patent Information Across Global Sequence Databases
9. Verdan Receives Patent on Crystal Deodorant Spray
10. My1Stop.com Expands Into Medical Wristbands Market with Patented LaserBand Printable Wristbands
11. Sandata Technologies and Infocrossing Settle Patent Infringement Suit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: